PATENT CLAIM ANALYSIS

Application Number: 15918765
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "228500"]

Abstract:
Pharmaceutical compositions comprising filgotinib maleate Form I and uses thereof are described herein.

Claim (Index 16):
The method of  claim 15  wherein the inflammatory disease or disorder is selected from the group consisting of rheumatoid arthritis, Crohn's disease, ulcerative colitis, alopecia areata, uveitis, acute graft-versus-host disease, cutaneous lupus nephritis, membranous lupus nephritis, atopic dermatitis, psoriasis, ankylosing spondylitis, and psoriatic arthritis.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14757585', '15481365', '15282128', '15670283', '14445970']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7715495737294469
- 35 USC 102 Novelty (BERT): 0.5057050842072671
- Combined Prediction Score: 0.744965124777229
- Mean Citation Score: 175.750366
- Max Citation Score: 195.06874
- Similarity Product: 110.67627842342851

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test